Patient-Funded Trials: Opportunity or Liability?

Cell Stem Cell 17 (2):135-137 (2015)
Download Edit this record How to cite View on PhilPapers
Patient-funded trials are gaining traction as a means of accelerating clinical translation. However, such trials sidestep mechanisms that promote rigor, relevance, efficiency, and fairness. We recommend that funding bodies or research institutions establish mechanisms for merit review of patient-funded trials, and we offer some basic criteria for evaluating PFT protocols
No keywords specified (fix it)
PhilPapers/Archive ID
Upload history
Archival date: 2015-11-21
View other versions
Added to PP index

Total views
298 ( #23,202 of 65,539 )

Recent downloads (6 months)
11 ( #51,785 of 65,539 )

How can I increase my downloads?

Downloads since first upload
This graph includes both downloads from PhilArchive and clicks on external links on PhilPapers.